Form 4 Tracker
David Malcom Rodman

Chief Medical Officer · 12 filings · Latest: May 11, 2026

Mineralys Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
MLYS
Rodman David MalcomFeb 12, 2026
Proposed Sale
$28.996,349$184.1K
MLYS
David Malcom RodmanChief Medical OfficerFeb 9, 2026
Sale
$30.212,171$65.6K50,437
MLYS
David Malcom RodmanChief Medical OfficerFeb 9, 2026
Option Exercise
$16.002,171$34.7K52,608
MLYS
Rodman David MalcomFeb 9, 2026
Proposed Sale
$30.212,171$65.6K
MLYS
David Malcom RodmanChief Medical OfficerJan 20, 2026
Sale
$32.10416$13.4K50,437
MLYS
David Malcom RodmanChief Medical OfficerJan 20, 2026
Option Exercise
$15.44416$6.4K50,853
MLYS
Rodman David MalcomJan 20, 2026
Proposed Sale
$32.10416$13.4K
MLYS
Rodman David MalcomJan 14, 2026
Proposed Sale
$32.6111,367$370.6K
MLYS
Rodman David MalcomJan 13, 2026
Proposed Sale
$32.757,709$252.5K
MLYS
Rodman David MalcomJan 12, 2026
Proposed Sale
$32.326,348$205.1K
MLYS
Rodman David MalcomJan 9, 2026
Proposed Sale
$33.272,170$72.2K
MLYS
Rodman David MalcomJan 2, 2026
Proposed Sale
$35.71262,752$9.4M
MLYS
Rodman David MalcomOct 15, 2025
Proposed Sale
$43.0110,369$446.0K
MLYS
Rodman David MalcomSep 15, 2025
Proposed Sale
$36.0011,367$409.3K
MLYS
Rodman David MalcomAug 13, 2025
Proposed Sale
$12.9311,365$147.0K
MLYS
Rodman David MalcomJul 14, 2025
Proposed Sale
$14.5911,366$165.9K
MLYS
Rodman David MalcomJun 13, 2025
Proposed Sale
$14.6011,366$165.9K
MLYS
Rodman David MalcomMay 14, 2025
Proposed Sale
$15.2911,366$173.8K
MLYS
Rodman David MalcomApr 14, 2025
Proposed Sale
$14.5311,366$165.2K
MLYS
Rodman David MalcomApr 1, 2025
Proposed Sale
$15.7655,771$879.0K